Israeli biopharmaceutical company BioLineRX, which develops therapies for cancer and rare diseases, has signed an agreement to conduct Phase 1 clinical trials of a potential treatment for sickle cell disease (SCD), at multiple locations in the US.  The trial is sponsored by St. Jude Children’s Research Hospital in Tennessee, which has affiliates across the country … Continue reading Israeli Biopharma Firm Leading US Trial Of Potential SCD Drug